Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART

J Assist Reprod Genet. 2005 Aug;22(7-8):277-83. doi: 10.1007/s10815-005-5998-8.

Abstract

Purpose: To study effects of endogenous LH levels on ovarian response and outcome in ART cycles a controlled study was performed with two patient groups differing in the intensity of pituitary downregulation.

Methods: Group I (n = 27) received 3.75 mg of the GnRH agonist triptorelin acetate depot, group II (n = 54) was given 0.1 mg triptorelin acetate daily, followed by ovarian stimulation with recombinant FSH.

Results: After downregulation serum LH and FSH levels were significantly lower in group I. Patients of group I needed significantly higher FSH doses to achieve comparable levels of serum estradiol and preovulatory follicles. The number of retrieved oocytes and transferable embryos was lower in group I.

Conclusion: Patients with profound endogenous LH suppression by depot GnRH agonists show higher FSH stimulation dose requirements and lower oocyte number and fertilization rate, indicating a need for minimal LH activity in folliculogenesis and oocyte development.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Delayed-Action Preparations
  • Down-Regulation
  • Estradiol / blood
  • Female
  • Follicle Stimulating Hormone / blood*
  • Gonadotropin-Releasing Hormone / agonists*
  • Humans
  • Injections, Subcutaneous
  • Luteinizing Hormone / blood*
  • Ovarian Function Tests
  • Ovary / drug effects*
  • Ovulation Induction / methods*
  • Pituitary Gland / drug effects
  • Sperm Injections, Intracytoplasmic
  • Treatment Outcome
  • Triptorelin Pamoate / administration & dosage*

Substances

  • Delayed-Action Preparations
  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone
  • Estradiol
  • Luteinizing Hormone
  • Follicle Stimulating Hormone